Us Bancorp \De\ Syros Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.26 - $4.66 $798 - $1,141	-245 Reduced 37.98%	400 $1,000
Q3 2021 Nov 10, 2021	SELL	$4.08 - $5.66 $2,288 - $3,175	-561 Reduced 46.52%	645 $3,000
Q2 2021 Aug 05, 2021	BUY	$5.01 - $7.48 $2,394 - $3,575	478 Added 65.66%	1,206 $7,000
Q4 2020 Feb 04, 2021	BUY	$6.66 - $14.66 $2,184 - $4,808	328 Added 82.0%	728 $8,000
Q3 2020 Nov 10, 2020	BUY	$8.69 - $14.47 $3,476 - $5,788	400 New	400 $4,000
Q4 2018 Feb 13, 2019	SELL	$5.55 - $11.34 $5,550 - $11,340	-1,000 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$8.45 - $17.48 $8,450 - $17,480	1,000	1,000 $10,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.